A handful of walnuts a day: could it keep the aging mind sharp?
NCT ID NCT06942351
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This study tests whether eating 1.5 ounces of walnuts every day for 12 weeks can improve memory, thinking speed, and flexibility in healthy adults aged 55 and older. Researchers will also check if walnuts reduce inflammation and oxidative stress, and whether they change the balance of bacteria in the gut. Half of the participants will eat walnuts, while the other half will eat calorie-matched crackers as a comparison.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Walnuts
- What this could lead to
- If walnuts improve cognitive function or gut health in older adults, this could point toward a simple dietary strategy to support healthy aging.
- What could go wrong
- This is a small, early-stage study, and results may not apply to everyone. Any benefits might be modest, and the study doesn't prove walnuts prevent dementia or other conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
90 people
The number who actually took part.
- Started
-
Jun 2025
- Expected to finish
-
May 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
55 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 55 years or older * Able to hear well enough to understand spoken instructions and questions * Able to see well enough to read and respond to printed instructions and fill out questionnaires (corrective lenses are allowed) * Able to write legibly and move a computer joystick with at least one hand (i.e., no injury or connective tissue or joint disorder that would impair ability to write or make hand movements) * Able to speak, read, and understand English * Score of greater than 79 on water maze learning task * Willing to maintain current eating patterns * Willing and able to complete the cognitive tests * Willing to stop consuming almonds, Brazil nuts, cashews, chestnuts, hazelnuts, macadamia nuts, peanuts, pecans, pistachios, walnuts, persimmons and pomegranates for 14 weeks. - are nuts or contain ellagitannins or ellagic acid - compounds/foods of interest for this study * Willing to limit oak aged wines and spirits to 1 serving/day and limit blackberries (including similar berries like boysenberries, marionberries, and olallieberries), cloudberries, cranberries, currants, elderberries, lingonberries, raspberries, strawberries, wolfberries, other native berries; guava, mango, muscadine grapes, nectarines, peaches, plums, pluots to 1 cup/day for 14 weeks; REMAIN CONSISTENT (consistent intake levels of): Coffee, tea, apple, apricots, blueberries, cherries, grapes (table/common) * Willing to stop probiotic supplements 2 weeks prior to and during the study (14 weeks) Exclusion Criteria: * Consumption of walnuts, pecans, and chestnuts combined greater than 2 oz / week in the past 3 months. * Use of oral antibiotics in the past month * Regular use of oral anti-inflammatory medications in the past month * Nut, wheat, or gluten allergy/intolerance * Pregnant or planning to become pregnant during the study period * Weighs less than 110 pounds * Diagnosis of sickle cell disease * Susceptibility to motion sickness * Consumes 3 or more alcoholic drinks daily * History of smoking tobacco products, including e-cigarettes and vaporizers in the past 2 years (smokeless tobacco use not exclusionary) * Use of psilocybin or cannabis products (including CBD-only products) in the past 2 years * Current treatment for alcohol or other substance use disorder * History of heart attack, heart failure, or stroke, including transient ischemic attack * History of liver disease or kidney disease requiring dialysis * History of cancer in the past 5 years (Skin cancer that was only surgically treated is not exclusionary) * History of bariatric surgery (e.g., gastric bypass, gastric banding, sleeve gastrectomy, etc.) or disorders (e.g., Crohn's disease, unmanaged celiac disease, ulcerative colitis) * History of thyroid disorder that requires medication, but subject is not taking medication * History of chronic bronchitis or emphysema * Diagnosis of dementia or Alzheimer's disease * History of head injury requiring hospitalization or loss of consciousness \> 5 minutes * History of chronic migraines (for at least 3 months, headache occurring on 15 or more days per month, where at least 8 of those headache days have migraine symptoms) * Blood pressure above 159 (systolic) or 99 (diastolic) mm Hg * Corrected vision worse than 20/50 * Score of less than 10/15 on Ishihara color vision test or diagnosis of color blindness * Score of less than 26/30 on Mini-Mental State Exam * Score of greater than 15 on Center for Epidemiologic Depression survey * History of disease or disorder which causes cognitive impairment, including but limited to: attention-deficit/hyperactivity disorder (ADHD), amyotrophic lateral sclerosis, autism, bipolar disorder, Down's syndrome, encephalitis, epilepsy/seizures, human immunodeficiency virus (HIV), Huntington's disease, Korsakoff's psychosis, multiple sclerosis, Parkinson's disease, or psychotic disorders (e.g., schizophrenia, schizoaffective disorder, schizophreniform disorder) * Current and regular use of any of the following medications: insulin, opioids, anti-seizure medications, psychotropic medications: stimulants, anti-psychotics, or medications that cause daytime drowsiness or difficulty concentrating
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Aging are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oregon State University
Corvallis, Oregon, 97331, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can sharing old memories boost mental Well-Being in old age?
- Can a Hands-On reflex therapy steady an older Person's stance?
- Scientists ask: when does a balance test score really improve?
- Gut check: can poop pills from young donors turn back the biological clock?
- Can a supplement duo quiet PCOS-Linked inflammation?
- Your smartwatch could soon warn you before you crash